Metachromatic Leukodystrophy


Myelin Sheath Lysosomal Storage Disease Metachromatic Leukodystrophy Myelin Membrane Composite Inclusion 


  1. Berger J, Loschl B, Bernheimer H, Lugowska A, Tylki-Szymanska A, Gieselmann V, and Molzer B (1997) Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy. Am J Med Genet 69: 335CrossRefPubMedGoogle Scholar
  2. Bosio A, Binczek E, and Stoffel W (1996) Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci USA 93: 13280CrossRefPubMedGoogle Scholar
  3. Kappler J, Leinekugel P, Conzelmann E, Kleijer WJ, Kohlschutter A, Tonnesen T, Rochel M, Freycon F, and Propping P (1991) Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency. Hum Genet 86: 463CrossRefPubMedGoogle Scholar
  4. Leinekugel P, Michel S, Conzelmann E, and Sandhoff K (1992) Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88: 513CrossRefPubMedGoogle Scholar
  5. Phelan MC, Thomas GR, Saul RA, Rogers RC, Taylor HA, Wenger, DA, and McDermid HE (1992) Cytogenetic, biochemical, and molecular analyses of a 22q13 deletion. Am J Med Genet 43: 872CrossRefPubMedGoogle Scholar
  6. Polten A, Fluharty AL, Fluharty CB, Kappler J, von Figura K, and Gieselmann V (1991) Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med 324: 18PubMedGoogle Scholar
  7. von Figura K, Gieselmann V, and Jaeken J (2001) Metachromatic leukodystrophy. In: The metabolic and molecular bases of inherited disease (Scriver D, Beaudet A, Valle D, and W. Sly WS, eds). New York: McGraw-Hill, pp 3695Google Scholar

Copyright information

© Springer-Verlag/Wien 2005

Personalised recommendations